<?xml version="1.0" encoding="UTF-8"?>
<ref id="B7">
 <label>7.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Han</surname>
    <given-names>X.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Wang</surname>
    <given-names>C.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Qin</surname>
    <given-names>C.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Xiang</surname>
    <given-names>W.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Fernandez-Salas</surname>
    <given-names>E.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Yang</surname>
    <given-names>C.Y.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Wang</surname>
    <given-names>M.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Zhao</surname>
    <given-names>L.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Xu</surname>
    <given-names>T.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Chinnaswamy</surname>
    <given-names>K.</given-names>
   </name>
   <etal>et al</etal>.
  </person-group>
  <article-title>Discovery of ARD-69 as a highly potent proteolysis targeting chimera (PROTAC) degrader of androgen receptor (AR) for the treatment of prostate cancer</article-title>. 
  <source>J. Med. Chem.</source>
  <year>2019</year>; 
  <volume>62</volume>:
  <fpage>941</fpage>â€“
  <lpage>964</lpage>.
  <pub-id pub-id-type="pmid">30629437</pub-id>
 </mixed-citation>
</ref>
